Login below, or create an account for free.
“This announcement heralds a new era for rare cancer patients. The additional research funding announced today will not only provide tangible improvement and better outcomes, but a beacon of hope for this often neglected group of Australians." More
Rare Cancers Australia has welcomed the December extended listing of Eisai's HALAVEN (eribulin) for the treatment of patients living with advanced liposarcoma. More
Stay up to date with the latest news including upcoming events, campaigns and announcements from Rare Cancers Australia.
Rare Cancers Australia hosts a vareity of events throughout the year in support of rare cancer awareness. Come along and support our work.
See all events.
Support Rare Cancers Australia by donating to a campaign, a fundraiser, or even by setting up your own fundraising page!
Find out more.
Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. In Australia in 2017, an estimated 52,000 people will be diagnosed with a RLC cancer and 25,000 will die from them, according to Cancer in Australia 2017 estimates.